Details of the Drug-Related molecule(s) Expression Atlas

General Information of Drug (ID: DMU49JN)

Drug Name

(R)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}alaninamide Drug Info

Synonyms

CHEMBL82327; 174756-44-6; (R)-2-((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanamide; AC1NUPG0; SCHEMBL194169; CHEBI:94774; BDBM50080950; ZINC26506755; AKOS030631890; AN-31998; BRD-K84639753-066-01-9; (R)-2-(4-(3-fluorobenzyloxy)benzylamino)propanamide

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 5487407
ChEBI ID: CHEBI:94774
TTD Drug ID: DMU49JN

Molecule(s) Related to This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Monoamine oxidase type B (MAO-B)	TTGP7BY	AOFB_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule	Molecule Type	Gene Name	Liver	Colon	Kidney	Small Intestine
Monoamine oxidase type B (MAO-B)	DTT	MAOB	9.367	6.907	8.237	8.409

Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease

Discovery agent

ICD Disease Classification

N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Monoamine oxidase type B (MAO-B)	DTT	MAOB	2.65E-02	1.12E-02	0.07

Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1	Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoa... J Med Chem. 2007 Oct 4;50(20):4909-16.